Egan Dwight H

Chief Executive Officer, DirectorCo-Diagnostics, Inc. (CODX) · full profile →Form 4 · filed Jan 20, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$419K
Net Open-Market Flow
-$419K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 15, 2021Sell(S)38K$11.00$419K0
Jan 15, 2021Tax withholding(F)12K$2.63$31K38K
Jan 15, 2021Option exercise(M)50K$2.63$132K50K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 15, 2021Option exercise(M)50K$050K

Transaction Codes

S
Open-market sale
F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-21-001459) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about CODX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001493152-21-001459"
Ask your agent
Use Arkolith to summarize insider buying and selling at Co-Diagnostics, Inc.
over the last 90 days and cite the filings.